Morin-Papunen L, Rautio K, Ruokonen A, Hedberg P, Puukka M, Tapanainen JS
At this time, GLP-1 drugs are not safe to use during pregnancy, and both patients and doctors must approach this matter
The pilot program will only be operational for ten medications and aims to start on January 1, 2026
--- PeptIQ helps you track compounds, cycle length, dose history, and response signals so decisions are based on data rather than guesswork.
These factors require baseline thyroid function tests and periodic reassessment
Metformin and GLP-1 medications target weight loss and glucose management through different biological pathways, making their combination a clinically sound strategy for many patients